Proove’s products and services are utilized throughout the country including Florida to help doctors efficiently prescribe pain treatments and lower healthcare costs. - Brian Meshkin, CEO, Proove Biosciences
Irvine, CA and Annapolis Junction, MD (PRWEB) June 30, 2014
Proove Biosciences, the commercial and research leader in personalized medicine, presented research and exhibited the company’s genetic testing products and services at the 2014 Florida Academy of Pain Medicine(FAPM) Scientific Meeting. The meeting was held in conjunction with the Florida Society of Physical Medicine and Rehabilitation and the American Academy of Regenerative Orthopedic Medicine.
“The research studies that we showcase illustrate how genetic testing can be an integral part of an effective personalized pain treatment regimen,” stated Brian Meshkin, President of Proove Biosciences. “Failed treatments for uncontrolled chronic pain lead to escalating healthcare costs and unnecessary patient suffering.”
FAPM’s meeting is the premier event for pain treatment professionals, researchers, and practitioners. The conference is designed to promote a better understanding of pain and features the latest products and techniques for pain management and diagnosis. In addition to scientific sessions, this year’s meeting included three hands-on preconference workshops and panel discussions about the legal and political challenges facing the practice of medicine.
“Florida has a startlingly high rate of prescription drug abuse and overdose deaths, and both the State and FAPM are on the cutting edge of developing new methods to combat the problem,” Meshkin said. “Proove’s products and services are utilized throughout the country including Florida to help doctors efficiently prescribe pain treatments and lower healthcare costs.”
About Proove Biosciences
Our mission is to change the future of medicine by providing proof to improve healthcare decisions. We envision a future when clinicians will know how patients are likely to respond to medications before writing a prescription. We believe such knowledge can be provided by genetic testing: Using a simple cheek swab, Proove performs proprietary genetic tests in its CLIA-certified laboratory. Healthcare providers use the results to evaluate how their patients will metabolize medications, and to screen for the likelihood of medication misuse.
Founded in 2009 with offices in Southern California and the Baltimore-Washington metropolitan area, Proove Biosciences is the leader in genetics-related personalized pain medicine research with hundreds of clinical research sites across the U.S. For more information, please visit http://www.proovebio.com or call toll free 855-PROOVE-BIO (855-776-6832).